| 产品详情 |
| Edit |   |
|---|
| Antigenic Specificity | Neu |
|---|
| Clone | polyclonal |
|---|
| Host Species | Rabbit |
|---|
| Reactive Species | mouse, rat, human |
|---|
| Isotype | n/a |
|---|
| Format | n/a |
|---|
| Size | 0.2 mg |
|---|
| Concentration | 0.200 mg/ml |
|---|
| Applications | Western Blot (WB), Immunopreciptation (IP), Immunohistochemistry (IHC) Paraffin |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | Neu (C18) Antibody. Specificity: Mouse, rat, and human Neu |
|---|
| Immunogen | Synthetic peptide mapping to the carboxy terminus of human Neu (HER2 or ErbB-2).Competition studies: A blocking peptide is also available for use in competition studies. Each vial contains 100ug of peptide in 0.5ml PBS with 0.1% sodium azide and 100 ug BSA. |
|---|
| Other Names | n/a |
|---|
| Gene, Accession # | n/a |
|---|
| Catalog # | MBS440046 |
|---|
| Price | |
|---|
| Order / More Info | Neu Antibody from MYBIOSOURCE INC. |
|---|
| Product Specific References | 1. Bernhard H, Salazar L, Schiffman K, Smorlesi A, Schmidt B, Knutson KL, Disis ML. Vaccination against the HER-2/neu oncogenic protein. Int J Endocr Relat Cancer 2002 Mar;9(1):33-44.2. Lohrisch C, Piccart M. HER2/neu as a predictive factor in breast cancer. Clin Breast Cancer 2001 Jul;2(2):129-35; discussion 136-7.3. Hortobagyi GN. Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer. Semin Oncol 2001 Dec;28(6 Suppl 18):43-7 |
|---|
| 产品资料 |
|
|